Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jul;15(4):359-362.
doi: 10.1370/afm.2099.

Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder

C Holly A Andrilla  1 , Cynthia Coulthard  2 , Eric H Larson  2
Affiliations

Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder

C Holly A Andrilla et al. Ann Fam Med. 2017 Jul.

Abstract

Opioid use disorder is a serious public health problem. Management with buprenorphine is an effective, office-based, medication-assisted treatment, but 60.1% of rural counties in the United States lack a physician with a Drug Enforcement Agency waiver to prescribe buprenorphine. This national study surveyed all rural physicians who have received a waiver in the United States and found that those who were not actively prescribing buprenorphine reported significantly more barriers than those who were, regardless of whether they were treating the maximum number of patients their waiver allowed. These findings suggest the need for tailored strategies to address barriers to providing buprenorphine for opioid use disorder and to support physicians who are adding or maintaining this service.

Keywords: buprenorphine; medication-assisted treatment; mental health care; opiate addiction; opiate substitution treatment; opioid treatment programs; rural health.

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest: authors report none.

References

    1. Substance Abuse and Mental Health Services Administration (SAMHSA). Key substance use and mental health indicators in the United States: Results from the 2015 national survey on drug use and health. https://www.samhsa.gov/data/sites/default/files/NSDUH-FFR1-2015/NSDUH-FF... Published Sep 2016. Accessed Aprl 25, 2017.
    1. Thomas CP, Fullerton CA, Kim M, et al. Medication-assisted treatment with buprenorphine: assessing the evidence. Psychiatr Serv. 2014;65(2):158–170. - PubMed
    1. Stein BD, Pacula RL, Gordon AJ, et al. Where is buprenorphine dispensed to treat opioid use disorders? The role of private offices, opioid treatment programs, and substance abuse treatment facilities in urban and rural counties. Milbank Q. 2015;93(3):561–583. - PMC - PubMed
    1. Andrilla CHA, Coulthard C, Larson EH. Changes in the Supply of Physicians With a DEA DATA Waiver to Prescribe Buprenorphine for Opioid Use Disorder. Data Brief #162. Seattle, WA: WAMI Rural Health Research Center; 2017.
    1. Rosenblatt RA, Andrilla CHA, Catlin M, Larson EH. Geographic and specialty distribution of US physicians trained to treat opioid use disorder. Ann Fam Med. 2015;13(1):23–26. - PMC - PubMed

Publication types